TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO)
TWD 8.0
(2.17%)
TWD 8.0
(2.17%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -57.65 Million TWD | 1.99% |
| 2022 | -58.83 Million TWD | 28.73% |
| 2021 | -82.54 Million TWD | 10.81% |
| 2020 | -92.55 Million TWD | -60.51% |
| 2019 | -57.66 Million TWD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -31.43 Million TWD | 2.24% |
| 2024 Q1 | -31.43 Million TWD | 45.48% |
| 2023 FY | -57.65 Million TWD | 1.99% |
| 2023 Q2 | -73.21 Million TWD | 0.94% |
| 2023 Q1 | -73.91 Million TWD | -25.64% |
| 2023 Q3 | -58.35 Million TWD | 20.3% |
| 2023 Q4 | -57.65 Million TWD | 1.2% |
| 2022 Q4 | -58.83 Million TWD | 1.16% |
| 2022 Q3 | -59.51 Million TWD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | 78.174% |
| Level Biotechnology Inc. | -453.9 Million TWD | 87.297% |
| Sagittarius Life Science Corp | -120.57 Million TWD | 52.179% |
| NeoCore Technology Co., Ltd. | -196.39 Million TWD | 70.642% |
| TaiMed Biologics Inc. | 499.84 Million TWD | 111.535% |
| GlycoNex Incorporation | -148.56 Million TWD | 61.191% |
| VBI | -25.31 Million TWD | -127.753% |
| GeneReach Biotechnology Corp. | 40.26 Million TWD | 243.193% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 141.783% |
| Visgeneer Inc. | 31.28 Million TWD | 284.305% |
| Mycenax Biotech Inc. | 207 Million TWD | 127.853% |
| Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 91.528% |
| G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | 57.052% |
| Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 109.277% |
| Enimmune corporation | -314.15 Million TWD | 81.647% |
| TaiRx, Inc. | -147.86 Million TWD | 61.007% |
| CHO Pharma, Inc. | -203.79 Million TWD | 71.707% |
| EirGenix Inc. | -4.58 Billion TWD | 98.743% |
| BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | 31.977% |
| Sunny Pharmtech Inc. | 120.87 Million TWD | 147.702% |
| Lin BioScience, Inc. | -3.21 Billion TWD | 98.208% |
| BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | 81.835% |
| Feng Chi Biotech Corp. | -19.81 Million TWD | -191.011% |
| Bio Preventive Medicine Corp. | 31.8 Million TWD | 281.263% |
| Lukas Biomedical Inc. | 50.75 Million TWD | 213.601% |
| RBC Bioscience Corporation | 422.18 Million TWD | 113.657% |
| BiOptic Inc. | 12.59 Million TWD | 557.894% |
| BRIM Biotechnology, Inc. | -944.4 Million TWD | 93.895% |
| Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | 43.186% |
| Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | 65.093% |
| Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 118.312% |
| Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | 25.162% |
| SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | 78.042% |
| Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 288.56% |
| Neith Corporation | -150.31 Million TWD | 61.641% |
| Advagene Biopharma Co., Ltd. | -64.32 Million TWD | 10.359% |
| NaviFUS Corp. | -123.12 Million TWD | 53.173% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 177.863% |
| Sinew Pharma Inc. | -160.34 Million TWD | 64.041% |
| Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | 76.164% |
| Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | 82.91% |
| Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | 86.027% |
| AP Biosciences Inc | -196.52 Million TWD | 70.662% |
| Medigen Biotechnology Corp. | 688.73 Million TWD | 108.372% |
| 3D Global Biotech Inc. | -11.43 Million TWD | -404.136% |
| Pharmosa Biopharm Inc. | -829.69 Million TWD | 93.051% |
| Intech Biopharm Corporation | 1.35 Billion TWD | 104.248% |
| Oneness Biotech Co., Ltd. | -414.87 Million TWD | 86.102% |
| Eusol Biotech Co.,Ltd. | -209.33 Million TWD | 72.457% |
| TWi Biotechnology, Inc. | -143.86 Million TWD | 59.922% |
| Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | 82.557% |
| TCI GENE Inc. | -689.25 Million TWD | 91.635% |
| MegaPro Biomedical Co., Ltd | -118.93 Million TWD | 51.523% |
| Senhwa Biosciences, Inc. | -1.3 Billion TWD | 95.596% |
| Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 381.492% |
| NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | 43.4% |
| PharmaEngine, Inc. | -860.8 Million TWD | 93.302% |
| Savior Lifetec Corporation | -812.54 Million TWD | 92.904% |
| TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | 80.779% |
| OBI Pharma, Inc. | -398.22 Million TWD | 85.521% |
| Meribank Biotech Co., Ltd | -365.41 Million TWD | 84.221% |
| Acepodia, Inc. | -6.02 Billion TWD | 99.042% |
| Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 98.305% |